TickerKhojComparison · NSE · data 2026-11-02
Divi's Laboratories Limited vs Zydus Lifesciences Limited
In plain words
Size: Divi's Laboratories Limited is about 2.1 times the market value of Zydus Lifesciences Limited.
Valuation (P/E): Divi's Laboratories Limited 90.2 vs Zydus Lifesciences Limited 27.8.
Return on equity: Zydus Lifesciences Limited 19.7% vs Divi's Laboratories Limited 16.2%.
Profit growth over 3 years: Zydus Lifesciences Limited 37% a year vs Divi's Laboratories Limited 12.1% a year.
Debt to equity: Zydus Lifesciences Limited 0.46 vs Divi's Laboratories Limited 0.
Differences in the numbers, not a recommendation of either stock.
Side by side
| DIVISLAB | ZYDUSLIFE | |
|---|---|---|
| Price | ₹9,940 | ₹1,247.3 |
| Market cap | ₹2,57,903 cr | ₹1,24,089 cr |
| P/E | 90.2 | 27.8 |
| P/B | — | — |
| ROE | 16.2% | 19.7% |
| ROCE | 18.0% | 17.8% |
| Debt / equity | 0 | 0.46 |
| Operating margin | 31.0% | 18.6% |
| Dividend yield | 0.31% | 0.08% |
| Sales growth, 3 years (yearly) | 10.8% | 16.6% |
| Profit growth, 3 years (yearly) | 12.1% | 37.0% |
| 1-year return | 49.7% | 26.5% |
| Revenue, last 12 months | ₹11,230 cr | ₹28,592 cr |
| Net profit, last 12 months | ₹2,925 cr | ₹4,513 cr |
| Latest quarter | Jun 2026 | Jun 2026 |
| Quarter net profit | ₹902 cr | ₹940 cr |
| Quarter profit vs a year earlier | +65.5% | -35.9% |
| Promoter holding | 51.88% | 75.01% |
| Health check | Average (6.4/10) | Strong (7.9/10) |
Common questions
Which has a higher P/E, Divi's Laboratories Limited or Zydus Lifesciences Limited?
Divi's Laboratories Limited trades at the higher P/E (90.2 against 27.8). A higher P/E means the market pays more for each rupee of past earnings; on its own it does not say which is better.
Which earns a higher return on equity?
Zydus Lifesciences Limited (19.7% against 16.2%).
Which carries more debt?
Zydus Lifesciences Limited has the higher debt-to-equity ratio (0.46 against 0).